
    
      120 men with a diagnosis of Erectile dysfunction (ED) will be randomized to one of three arms
      in the study, DHEA (50 mg), testosterone [T] (80 mg) or placebo. Patients will be evaluated
      after starting blinded medication at 30 day intervals for a total of 90 days. Response will
      be evaluated with blood parameters, physical examination including rectal examination,
      validated questionnaires and global assessment scales.
    
  